Management of stage I to stage III periodontitis in adults Oral Health
Conditions
Interventions
Patients with chronic periodontitis were randomly assigned to the test and control groups using computer-generated random numbers following the completion of screening assessments. The test group used
Sponsors
College of Dental Science
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with an age group between 20 and 45 years 2. The selected patients should have mild to moderate periodontal pockets (5-7 mm) clinically with radiographic evidence of bone loss, or periodontitis stage II (maximum probing depth =5 mm and radiographic bone loss of 15% to 33%, coronal third) and periodontitis stage III (probing pocket depth =6mm and radiographic bone loss extending to mid-third of root and be-yond) according to the 2017 World Workshop classification
Exclusion criteria
Exclusion criteria: 1. Suffering from systemic diseases such as migraine, insomnia, as well as smokers, alcoholics, pregnant, and lactating individuals 2. Individuals who had taken antibiotics or anti-inflammatory drugs within the past month were excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Full mouth plaque score is measured using the plaque index at baseline, 1 month, and 3 months 2. Gingival inflammation is measured using the gingival index at baseline, 1 month, and 3 months 3. Gingival bleeding is measured using the gingival bleeding index at baseline, 1 month, and 3 months 4. Probing pocket depth (PPD) is measured using the UNC-15 probe at baseline, 1 month, and 3 months 5. Clinical attachment level (CAL) is measured using the UNC-15 probe at baseline, 1 month, and 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Salivary Superoxide Dismutase (SOD) levels measured using spectrophotometry at baseline, 1 month, and 3 months | — |
Countries
India
Contacts
Public ContactRashmi Srinath
Outcome results
None listed